Table 1 Clinical Characteristic of patients of acromegaly with and without diabetes.
From: Impact of concurrent diabetes on periodontal health in patients with acromegaly
Parameters | Acromegaly with diabetes (Group A) | Acromegaly without diabetes (Group B) | Controls (Group C) | P-value A vs. B | P-value A vs. C | P-value B vs. C |
|---|---|---|---|---|---|---|
Number of patients | N = 11 | N = 11 | N = 20 | – | – | – |
Age (Yrs.) | 41.8 ± 3.2 | 35.0 ± 3.7 | 37.2 ± 2.6 | 0.395 | 0.581 | 0.875 |
Gender (M: F) | 7:4 | 6:5 | 13:7 | – | – | – |
Acromegaly active disease | 11/11 | 11/11 | – | 1 | ||
BMI (kg/m2) | 28.4 ± 1.1 | 24.3 ± 1.5 | 24.0 ± 0.5 | 0.031* | 0.007** | 0.970 |
Mean BP [systolic/diastolic (mm/Hg)] | 123.0 ± 1.0/79.0 ± 2.0 | 127.0 ± 4.0/80.0 ± 3.0 | 128.0 ± 1.0/81.0 ± 2.0 | 0.575/0.872 | 0.307/0.760 | 0.939/0.989 |
Duration of acromegaly (Yrs.) | 5.4 ± 0.8 | 5.5 ± 0.9 | – | 0.623 | ||
Acral enlargement | 11/11 | 11/11 | – | 1 | ||
Macroglossia | 11/11 | 9/11 | – | 0.118 | ||
Interdental spacing | 10/11 | 6/11 | – | 0.036* | ||
Hypertension | 3/11 | 4/11 | – | 0.646 | ||
Hyperprolactinemia | 5/11 | 4/11 | – | 0.663 | ||
Hypogonadism | 11/11 | 11/11 | – | 1 | ||
Hypothyroidism | 1/11 | 2/11 | – | 0.531 | ||
Hypocortisolism | 8/11 | 9/11 | – | 0.609 |
